Drug Profile
Diphenhydramine/lorazepam/zolpidem - Sequential Medicine
Alternative Names: SM 1Latest Information Update: 30 Sep 2020
Price :
$50
*
At a glance
- Originator Sequential Medicine Ltd
- Class Acetamides; Anxiolytics; Benzodiazepines; Benzodiazepinones; Hypnosedatives; Sedating antihistamines; Sleep disorder therapies; Small molecules
- Mechanism of Action GABA A receptor agonists; Histamine H1 receptor antagonists; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Insomnia
Most Recent Events
- 30 Sep 2020 No development reported - Phase-III for Insomnia in USA (PO)
- 20 May 2020 Sequential Medicine plans a phase II trial for Insomnia in USA (NCT04396327)
- 20 Mar 2018 Sequential Medicine completes a phase III trial in Insomnia in USA (PO) (NCT03331042)